BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Song DS, Yang JM, Yoon EL;  APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353-390. [PMID: 31172417 DOI: 10.1007/s12072-019-09946-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 44.7] [Reference Citation Analysis]
Number Citing Articles
1 Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shi Y, Fan Y, Chen T. Editorial: Acute-On-Chronic Liver Failure: Natural History, Mechanism, and Treatment. Front Med 2022;9:867436. [DOI: 10.3389/fmed.2022.867436] [Reference Citation Analysis]
3 Liu XQ, Zhang XY, Ying Y, Zheng JM, Sun J, Zhang WH, Zhang JM, Huang YX. The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study. Infect Dis Poverty 2021;10:44. [PMID: 33789759 DOI: 10.1186/s40249-021-00830-7] [Reference Citation Analysis]
4 Maiwall R, Pasupuleti SSR, Chandel SS, Narayan A, Jain P, Mitra LG, Kumar G, Moreau R, Sarin SK. Co-orchestration of acute kidney injury and non-kidney organ failures in critically ill patients with cirrhosis. Liver Int 2021;41:1358-69. [PMID: 33534915 DOI: 10.1111/liv.14809] [Reference Citation Analysis]
5 Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, Jing J, Zhang JJ, Fu SN, Wang X, Liang XX, Li X, Gong M, Li J. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(30): 4479-4488 [PMID: 32874059 DOI: 10.3748/wjg.v26.i30.4479] [Reference Citation Analysis]
6 He K, Qian YB, Xi ZF, Zhao J, Chen XS, Xia Q. Responding to the coronavirus disease 2019 pandemic with a rapid rescue plan for patients with acute or acute-on-chronic liver failure by living-donor liver transplantation. J Dig Dis 2020;21:735-6. [PMID: 33111491 DOI: 10.1111/1751-2980.12956] [Reference Citation Analysis]
7 Chen Y, Sun J, Fan X, Wang X, Zeng L, Zhang X, Zhang K, Li N, Han Q, Liu Z. Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure. Front Pharmacol 2021;12:648736. [PMID: 33967787 DOI: 10.3389/fphar.2021.648736] [Reference Citation Analysis]
8 Gao Y, Tian Y, Zhang X, Zhang X, Duan Z, Ren F, Chen Y. Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway. Immunopharmacol Immunotoxicol 2020;42:445-55. [PMID: 32787473 DOI: 10.1080/08923973.2020.1808984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment. JHEP Rep 2021;3:100176. [PMID: 33205036 DOI: 10.1016/j.jhepr.2020.100176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Snehavardhan P, Lal BB, Sood V, Khanna R, Alam S. Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood—A Double-blind Randomized Controlled Trial. Journal of Pediatric Gastroenterology & Nutrition 2020;70:165-70. [DOI: 10.1097/mpg.0000000000002521] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zhang M, Li G, Shang J, Pan C, Zhang M, Yin Z, Xie Q, Peng Y, Mao Q, Xiao X, Jiang Y, Luo K, Xu Y, Ding H, Fan W, Diego V, Pourkarim MR, De Clercq E, Wang G, Gong G. Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study. Hepatol Int 2020;14:212-24. [PMID: 32100261 DOI: 10.1007/s12072-020-10015-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Feng Y, Wang AT, Jia HH, Zhao M, Yu H. A Brief Analysis of Mesenchymal Stem Cells as Biological Drugs for the Treatment of Acute-on-Chronic Liver Failure (ACLF): Safety and Potency. Curr Stem Cell Res Ther 2020;15:202-10. [PMID: 31893994 DOI: 10.2174/1574888X15666200101124317] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen F, Shi Y, Liu X, Lei L, Xu J. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol 2019;13:1129-35. [PMID: 31674256 DOI: 10.1080/17474124.2019.1688143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Cui B, Guo G, Hui Y, Wang X, Liu W, Sun C. The prognostic value of high-density lipoprotein cholesterol in patients with decompensated cirrhosis: a propensity score matching analysis. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.03.009] [Reference Citation Analysis]
15 Kulkarni AV, Sharma M, Kumar P, Simhadri V, Sowmya TR, Mitnala S, Nageshwar Reddy D, Nagaraja Rao P. Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failure. J Clin Exp Hepatol 2021;11:201-8. [PMID: 33746445 DOI: 10.1016/j.jceh.2020.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kim JH, Kim SE, Song DS, Kim HY, Yoon EL, Kim TH, Jung YK, Suk KT, Jun BG, Yim HJ, Kwon JH, Lee SW, Kang SH, Kim MY, Jeong SW, Jang JY, Yoo JJ, Kim SG, Jin YJ, Cheon GJ, Kim BS, Seo YS, Kim HS, Sinn DH, Chung WJ, Kim HY, Lee HA, Nam SW, Kim IH, Suh JI, Kim JH, Chae HB, Sohn JH, Cho JY, Kim YJ, Yang JM, Park JG, Kim W, Cho HC, Kim DJ. Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration. J Clin Med 2022;11:2463. [PMID: 35566588 DOI: 10.3390/jcm11092463] [Reference Citation Analysis]
17 Zhou X, Li Y, Ji Y, Liu T, Zhao N, He J, Yao J. PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure. J Clin Transl Hepatol 2021;9:283-90. [PMID: 34221914 DOI: 10.14218/JCTH.2020.00142] [Reference Citation Analysis]
18 Li J, Hu CH, Chen Y, Zhou MM, Gao ZJ, Fu MJ, Wang J, Li JZ, Chen TY, Zhao YR, He YL. Characteristics of Peripheral Lymphocyte Subsets in Patients With Acute-On-Chronic Liver Failure Associated With Hepatitis B. Front Med (Lausanne) 2021;8:689865. [PMID: 34386507 DOI: 10.3389/fmed.2021.689865] [Reference Citation Analysis]
19 Cheung A, Kwo P. Viral Hepatitis Other than A, B, and C: Evaluation and Management. Clin Liver Dis 2020;24:405-19. [PMID: 32620280 DOI: 10.1016/j.cld.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sun J, Yu X, Weng Z, Jin L, Yang J, Zhang H, Gu J, Wang N, Yang J. The impact of hepatotoxic drugs on the outcome of patients with acute deterioration of hepatitis B virus-related chronic disease. Eur J Gastroenterol Hepatol 2022;34:782-90. [PMID: 35506899 DOI: 10.1097/MEG.0000000000002365] [Reference Citation Analysis]
21 Zanetto A, Shalaby S, Gambato M, Germani G, Senzolo M, Bizzaro D, Russo FP, Burra P. New Indications for Liver Transplantation. J Clin Med 2021;10:3867. [PMID: 34501314 DOI: 10.3390/jcm10173867] [Reference Citation Analysis]
22 Nautiyal N, Maheshwari D, Tripathi DM, Kumar D, Kumari R, Gupta S, Sharma S, Mohanty S, Parasar A, Bihari C, Biswas S, Rastogi A, Maiwall R, Kumar A, Sarin SK. Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction. Hepatol Int 2021. [PMID: 34435344 DOI: 10.1007/s12072-021-10244-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 . Expert consensus on perioperative management of liver transplantation in adults with acute-on-chronic liver failure. Liver Research 2021;5:37-44. [DOI: 10.1016/j.livres.2021.03.002] [Reference Citation Analysis]
24 Kim A, Niu B, Woreta T, Chen PH. Clinical Considerations of Coagulopathy in Acute Liver Failure. J Clin Transl Hepatol 2020;8:407-13. [PMID: 33447524 DOI: 10.14218/JCTH.2020.00058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Wu T, Chen T, Ning Q. Validation of non-invasive tools in predicting HBV-related acute-on-chronic liver failure. Hepatol Int 2021;15:571-4. [PMID: 34142336 DOI: 10.1007/s12072-021-10185-8] [Reference Citation Analysis]
26 Yang L, Wu T, Li J, Xin J, Shi D, Jiang J, Liang X, Lu Y, Yao H, Zhang H, Sun S, Li T, Mohamed Hassan Mohamed H, Li J, Ren K, Guo B, Zhou X, Chen J, Hao S, Chen J, Xin S, Pan C, Han T, Chen Y, Lin S, Duan Z, Xu X, Huang J, Chen X, Li L, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: A case-control matched analysis. Hepatol Res 2020;50:656-70. [PMID: 32134538 DOI: 10.1111/hepr.13497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Wang X, Sun M, Yang X, Gao L, Weng M, Yang D, Li H, Zhou X, Li J, Qin S, Zhou D, Wu X, Tang S, Zeng W. Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Biomed Res Int 2020;2020:5062873. [PMID: 32832550 DOI: 10.1155/2020/5062873] [Reference Citation Analysis]
28 Sukezaki A, Chu PS, Shinoda M, Hibi T, Taniki N, Yoshida A, Kawaida M, Hori S, Morikawa R, Kurokouchi A, Wakino S, Kameyama K, Obara H, Kitagawa Y, Saito H, Kanai T, Nakamoto N. Late-onset acute liver failure due to Wilson's disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review. Clin J Gastroenterol 2020;13:1239-46. [PMID: 32643122 DOI: 10.1007/s12328-020-01175-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M; APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 91] [Cited by in F6Publishing: 1] [Article Influence: 45.5] [Reference Citation Analysis]
30 Moreau R, Gao B, Papp M, Bañares R, Kamath PS. Acute-on-chronic liver failure: A distinct clinical syndrome. J Hepatol 2021;75 Suppl 1:S27-35. [PMID: 34039489 DOI: 10.1016/j.jhep.2020.11.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Nie C, Zhang L, Chen X, Li Y, Ha F, Liu H, Han T. Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure. J Clin Transl Hepatol 2020;8:240-5. [PMID: 33083245 DOI: 10.14218/JCTH.2020.00045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Huang Y, Cai J, Ha F, Guo B, Xin S, Duan Z, Han T. Characteristics of acute kidney injury and its impact on outcome in patients with acute-on-chronic liver failure. BMC Gastroenterol 2022;22:231. [PMID: 35545763 DOI: 10.1186/s12876-022-02316-8] [Reference Citation Analysis]
33 Ayyala-Somayajula D, Han H, Terrault NA. Selective use of liver transplantation for severe alcohol-associated hepatitis. Expert Rev Gastroenterol Hepatol 2020;14:175-84. [PMID: 32077333 DOI: 10.1080/17474124.2020.1733414] [Reference Citation Analysis]
34 Shi H, Xiao G, Liao M, Zheng L, Jie Y, Lin G, Chong Y. Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failure. Biomed Pharmacother 2021;134:111118. [PMID: 33341047 DOI: 10.1016/j.biopha.2020.111118] [Reference Citation Analysis]
35 Chen JF, Weng WZ, Huang M, Peng XH, He JR, Zhang J, Xiong J, Zhang SQ, Cao HJ, Gao B, Lin DN, Gao J, Gao ZL, Lin BL. Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:692669. [PMID: 34222294 DOI: 10.3389/fmed.2021.692669] [Reference Citation Analysis]
36 Li Y, Kong Y, Shi K, Huang Y, Zhang Q, Zhu B, Zeng H, Wang X. CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure. Front Med (Lausanne) 2021;8:762296. [PMID: 34938747 DOI: 10.3389/fmed.2021.762296] [Reference Citation Analysis]
37 Xu X, Li C, Chen J, Liu X, Su H, Tong J, Hu J. Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118640] [Reference Citation Analysis]
38 Liu F, Long X, Ji G, Zhang B, Zhang W, Zhang Z, Chen X. Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes. J Infect. 2020;81:e178-e180. [PMID: 32562796 DOI: 10.1016/j.jinf.2020.06.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Xu M, Kong M, Yu P, Cao Y, Liu F, Zhu B, Zhang Y, Lu W, Zou H, You S, Xin S, Duan Z, Han T, Chen Y. Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:750061. [PMID: 34722587 DOI: 10.3389/fmed.2021.750061] [Reference Citation Analysis]
40 Ye Q, Cai JJ, Yan JQ, Lv R. Role of L3-PMI in prognostic evaluation of patients with acute-on-chronic liver failure related to hepatitis B cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(20): 1167-1173 [DOI: 10.11569/wcjd.v29.i20.1167] [Reference Citation Analysis]
41 Kumar R, Mehta G, Jalan R. Acute-on-chronic liver failure. Clin Med (Lond). 2020;20:501-504. [PMID: 32934045 DOI: 10.7861/clinmed.2020-0631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
42 Hernaez R, Liu Y, Kramer JR, Rana A, El-serag HB, Kanwal F. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. Journal of Hepatology 2020;73:1425-33. [DOI: 10.1016/j.jhep.2020.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
43 Xu MM, Kong M, Yu PF, Cao YY, Liu F, Zhu B, Zhang YZ, Lu W, Zou HB, Duan BW, You SL, Xin SJ, Han T, Duan ZP, Chen Y. Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study. J Clin Transl Hepatol 2021;9:626-34. [PMID: 34722177 DOI: 10.14218/JCTH.2020.00179] [Reference Citation Analysis]
44 Choi JW, Son HJ, Lee SS, Jeon H, Cho J, Kim HJ, Cha RR, Lee JM, Kim HJ, Jung WT, Lee O. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07050-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li P, Liang X, Xu S, Xiong Y, Huang J. A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure. Sci Rep 2021;11:2975. [PMID: 33536531 DOI: 10.1038/s41598-021-82719-x] [Reference Citation Analysis]
46 Tanaka A. Autoimmune Hepatitis: 2019 Update. Gut Liver 2020;14:430-8. [PMID: 32301319 DOI: 10.5009/gnl19261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
47 Sarin SK, Sharma S. Predictors of steroid non-response and new approaches in severe alcoholic hepatitis. Clin Mol Hepatol 2020;26:639-51. [PMID: 33053936 DOI: 10.3350/cmh.2020.0196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chen J, Huang ZB, Li H, Zheng X, Chen JJ, Wang XB, Qian ZP, Liu XX, Fan XG, Hu XW, Liao CJ, Long LY, Huang Y. Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infect Dis Ther 2021;10:281-90. [PMID: 33146854 DOI: 10.1007/s40121-020-00362-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Thakur V, Ratho RK, Kumar S, Saxena SK, Bora I, Thakur P. Viral Hepatitis E and Chronicity: A Growing Public Health Concern. Front Microbiol 2020;11:577339. [PMID: 33133046 DOI: 10.3389/fmicb.2020.577339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Xu M, Li T, Kong M, Geng N, Song W, Guo G, Duan Z, Han Y, Chen Y. Psoas Muscle Index Can Be Used to Predict Long-Term Mortality in Young Male Patients With Acute-on-Chronic Liver Failure. Front Nutr 2022;9:811826. [DOI: 10.3389/fnut.2022.811826] [Reference Citation Analysis]
51 Ling S, Jiang G, Que Q, Xu S, Chen J, Xu X. Liver transplantation in patients with liver failure: twenty years of experience from China. Liver Int 2022. [PMID: 35532977 DOI: 10.1111/liv.15288] [Reference Citation Analysis]
52 Yu Z, Zhang Y, Cao Y, Xu M, You S, Chen Y, Zhu B, Kong M, Song F, Xin S, Duan Z, Han T. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep 2021;11:1810. [PMID: 33469110 DOI: 10.1038/s41598-021-81431-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Shah S, Goldberg DS. Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation. Curr Opin Gastroenterol 2021;37:173-8. [PMID: 33606401 DOI: 10.1097/MOG.0000000000000722] [Reference Citation Analysis]
54 McMillin M. Can Weather Influence the Prevalence of Acute-on-chronic Liver Failure? J Clin Transl Hepatol 2019;7:285-6. [PMID: 31915595 DOI: 10.14218/JCTH.2019.00058] [Reference Citation Analysis]
55 Maheshwari D, Kumar D, Jagdish RK, Nautiyal N, Hidam A, Kumari R, Sehgal R, Trehanpati N, Baweja S, Kumar G, Sinha S, Bajpai M, Pamecha V, Bihari C, Maiwall R, Sarin SK, Kumar A. Bioenergetic Failure Drives Functional Exhaustion of Monocytes in Acute-on-Chronic Liver Failure. Front Immunol 2022;13:856587. [DOI: 10.3389/fimmu.2022.856587] [Reference Citation Analysis]
56 Ocskay K, Kanjo A, Gede N, Szakács Z, Pár G, Erőss B, Stange J, Mitzner S, Hegyi P, Molnár Z. Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis. Ann Intensive Care 2021;11:10. [PMID: 33462764 DOI: 10.1186/s13613-020-00795-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Dong X, He J, Chen W, Su R, Xu Y, Sheng X, Li L, Cao H. Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria. Sci Rep 2020;10:8577. [PMID: 32444697 DOI: 10.1038/s41598-020-65529-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kulkarni AV, Tirumalle S, Premkumar M, Kumar K, Fatima S, Rapole B, Simhadri V, Gora BA, Sasikala M, Gujjarlapudi D, Yelamanchili S, Sharma M, Gupta R, Rao PN, Reddy DN. Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial. Am J Gastroenterol 2022;117:607-16. [PMID: 35041634 DOI: 10.14309/ajg.0000000000001611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
59 Jing J, Sang XX, You SL, Zhu B, Cui YF, Li CY, Wang ZX, Zhao X, Liu XY, Tian M, Ren YB, Yu SM, Xiao XH, Wang JB, Niu M, Wang RL. Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute-on-chronic liver failure: A pilot study. Hepatol Res 2021;51:490-502. [PMID: 33227168 DOI: 10.1111/hepr.13594] [Reference Citation Analysis]
60 Shah D, Gupta E, Baweja S, Pasupuleti SSR, Maiwall R, Ramalingam A, Mitra LG, Sarin SK. CYTOMEGALOVIRUS REACTIVATION IN SEROPOSITIVE CRITICALLY ILL PATIENTS WITH LIVER CIRRHOSIS: A HOSPITAL-BASED LONGITUDINAL STUDY. Journal of Clinical Virology Plus 2022. [DOI: 10.1016/j.jcvp.2022.100087] [Reference Citation Analysis]
61 Shang J, Wang M, Wen Q, Ma Y, Chen F, Xu Y, Liu CH, Bai L, Tang H. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep 2021;11:7510. [PMID: 33820919 DOI: 10.1038/s41598-021-87055-8] [Reference Citation Analysis]
62 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.003] [Reference Citation Analysis]
63 Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res 2022;52:417-21. [PMID: 35591813 DOI: 10.1111/hepr.13763] [Reference Citation Analysis]
64 Wu J, Xue R, Wu M, Yin X, Xie B, Meng Q, Szewczyk-golec K. Nrf2-Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute-on-Chronic Liver Failure. Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/4505513] [Reference Citation Analysis]
65 Ge J, Najafi N, Zhao W, Somsouk M, Fang M, Lai JC. A Methodology to Generate Longitudinally Updated Acute-On-Chronic Liver Failure Prognostication Scores From Electronic Health Record Data. Hepatol Commun 2021;5:1069-80. [PMID: 34141990 DOI: 10.1002/hep4.1690] [Reference Citation Analysis]
66 Liu H, Zhang Q, Liu L, Cao Y, Ye Q, Liu F, Liang J, Wen J, Li Y, Han T. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Artif Organs 2020;44:E434-47. [PMID: 32320491 DOI: 10.1111/aor.13710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Sun J, Guo H, Yu X, Zhu H, Zhang X, Yang J, Wang J, Qian Z, Shen Z, Mao R, Zhang J. A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure. BMC Gastroenterol 2021;21:422. [PMID: 34758747 DOI: 10.1186/s12876-021-02007-w] [Reference Citation Analysis]
68 Li J, Hu C, Chen Y, Zhang R, Fu S, Zhou M, Gao Z, Fu M, Yan T, Yang Y, Li J, Liu J, Chen T, Zhao Y, He Y. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B. BMC Infect Dis 2021;21:567. [PMID: 34126939 DOI: 10.1186/s12879-021-06237-x] [Reference Citation Analysis]
69 Liang J, Liu L, Cao Y, Zhang Q, Liu F, Chen Y, Liu H, Duan Z, Xu M, Xin S, You S, Song F, Li J, Han T. Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult. BMC Infect Dis 2021;21:1273. [PMID: 34930163 DOI: 10.1186/s12879-021-06974-z] [Reference Citation Analysis]
70 Zou X, Fang M, Li S, Wu L, Gao B, Gao H, Ran X, Bian Y, Li R, ShanshanYu, Ling J, Li D, Tian D, Huang J. Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection. Clin Gastroenterol Hepatol. 2021;19:597-603. [PMID: 32553907 DOI: 10.1016/j.cgh.2020.06.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
71 Mao G, Li C, Wang H, Jv YH, Zhang Y, Liu L, Tang M. Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/7922906] [Reference Citation Analysis]
72 Zhang X, Han J, Qi X, Zhang Y, Zhou P, Liu X, Ying Y, Zhang W, Zhang J, Huang Y. DIC Score Combined With CLIF-C OF Score Is More Effective in Predicting Prognosis in Patients With Hepatitis B Virus Acute-on-Chronic Liver Failure. Front Med 2022;9:815580. [DOI: 10.3389/fmed.2022.815580] [Reference Citation Analysis]
73 Sharma S, Agarwal S, Kaushal K, Anand A, Gunjan D, Yadav R, Saraya A. Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 2021;5:81-90. [PMID: 33490617 DOI: 10.1002/jgh3.12451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Chiriac S, Stanciu C, Cojocariu C, Singeap AM, Sfarti C, Cuciureanu T, Girleanu I, Igna RA, Trifan A. Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure. World J Clin Cases 2021; 9(3): 552-564 [PMID: 33553393 DOI: 10.12998/wjcc.v9.i3.552] [Reference Citation Analysis]
75 Fantilli A, López Villa SD, Zerega A, Di Cola G, López L, Wassaf Martínez M, Pisano MB, Ré VE. Hepatitis E virus infection in a patient with alcohol related chronic liver disease: a case report of acute-on-chronic liver failure. Virol J 2021;18:245. [PMID: 34886883 DOI: 10.1186/s12985-021-01714-w] [Reference Citation Analysis]
76 Khanam A, Kottilil S. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Front Med (Lausanne) 2021;8:752875. [PMID: 34820395 DOI: 10.3389/fmed.2021.752875] [Reference Citation Analysis]
77 Chen W, Zhang Q, Li S, Liang R, Liang H, Yu Y, Qiu C, Lv J, Zhang W. Acute-on-Chronic Liver Failure Precipitated by Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a Patient with Hepatitis B Virus-Related Cirrhosis: A Case Report. Infectious Diseases & Immunity 2021;1:169-73. [DOI: 10.1097/id9.0000000000000023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Du B, Teng J, Yin R, Tian Y, Jiang T, Du Y, Cai W. Increased Circulating T Follicular Helper Cells Induced via IL-12/21 in Patients With Acute on Chronic Hepatitis B Liver Failure. Front Immunol 2021;12:641362. [PMID: 33868273 DOI: 10.3389/fimmu.2021.641362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Verma N, Dhiman RK, Singh V, Duseja A, Taneja S, Choudhury A, Sharma MK, Eapen CE, Devarbhavi H, Al Mahtab M, Shukla A, Hamid SS, Jafri W, Butt AS, Ning Q, Chen T, Tan SS, Lesmana LA, Lesmana CRA, Sahu MK, Hu J, Lee GH, Sood A, Midha V, Goyal O, Ghazinian H, Kim DJ, Treeprasertsuk S, Mohan Prasad VG, Dokmeci AK, Sollano JD, Shah S, Payawal DA, Rao PN, Kulkarni A, Lau GK, Duan Z, Chen Y, Yokosuka O, Abbas Z, Karim F, Chowdhury D, Prasad AS, Sarin SK; APASL ACLF Working Party. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF. Hepatol Int 2021;15:753-65. [PMID: 34173167 DOI: 10.1007/s12072-021-10175-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Yu X, Lu Y, Sun S, Tu H, Xu X, Gong K, Yao J, Shi Y, Sheng J. Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report. J Clin Transl Hepatol 2021;9:838-49. [PMID: 34966647 DOI: 10.14218/JCTH.2021.00005] [Reference Citation Analysis]
81 Yao X, Yu H, Fan G, Xiang H, Long L, Xu H, Wu Z, Chen M, Xi W, Gao Z, Liu C, Gong W, Yang A, Sun K, Yu R, Liang J, Xie B, Sun S. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2021;11:573923. [PMID: 33889550 DOI: 10.3389/fcimb.2021.573923] [Reference Citation Analysis]
82 Tang L, Wang F, Xiao L, Shen M, Xia S, Zhang Z, Zhang F, Zheng S, Tan S. Yi-Qi-Jian-Pi formula modulates the PI3K/AKT signaling pathway to attenuate acute-on-chronic liver failure by suppressing hypoxic injury and apoptosis in vivo and in vitro. J Ethnopharmacol 2021;280:114411. [PMID: 34265380 DOI: 10.1016/j.jep.2021.114411] [Reference Citation Analysis]
83 Kulkarni AV, Anand L, Vyas AK, Premkumar M, Choudhury AK, Trehanpati N, Benjamin J, Kumar G, Joshi YK, Sarin SK. Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial. J Gastroenterol Hepatol 2021;36:1953-61. [PMID: 33450081 DOI: 10.1111/jgh.15400] [Reference Citation Analysis]
84 Wen X, Tong J, Yao M, Hu J, Lu F. Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF. J Hepatol 2021;75:243-5. [PMID: 33647347 DOI: 10.1016/j.jhep.2021.02.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Seetharam A. Intensive Care Management of Acute Liver Failure: Considerations While Awaiting Liver Transplantation. J Clin Transl Hepatol 2019;7:384-91. [PMID: 31915608 DOI: 10.14218/JCTH.2019.00032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
86 Chang Y, Liu QY, Zhang Q, Rong YM, Lu CZ, Li H. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(29): 4288-4301 [PMID: 32848334 DOI: 10.3748/wjg.v26.i29.4288] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Kumar U, Sharma S, Durgappa M, Gupta N, Raj R, Kumar A, Sharma PN, Krishna VP, Kumar RV, Guleria A, Saraswat VA, Pande G, Kumar D. Serum Metabolic Disturbances Associated with Acute-on-chronic Liver Failure in Patients with Underlying Alcoholic Liver Diseases: An Elaborative NMR-based Metabolomics Study. J Pharm Bioallied Sci 2021;13:276-82. [PMID: 34349490 DOI: 10.4103/JPBS.JPBS_333_20] [Reference Citation Analysis]
88 Li T, Xu M, Kong M, Song W, Duan Z, Chen Y. Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure. Sci Rep 2021;11:12593. [PMID: 34131260 DOI: 10.1038/s41598-021-92087-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chen C, Zhang SY, Chen L. Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure. World J Clin Cases 2022; 10(19): 6341-6348 [DOI: 10.12998/wjcc.v10.i19.6341] [Reference Citation Analysis]
90 Philips CA, Ahamed R, Abduljaleel JK, Rajesh S, Augustine P. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021;13:e19152. [PMID: 34733599 DOI: 10.7759/cureus.19152] [Reference Citation Analysis]
91 Yang W, Yu H, Huang J, Miao X, Wang Q, Wang Y, Cheng Y, He S, Zhao F, Meng L, Wang B, Qian F, Ren X, Jin M, Gu Y, Zhang Y, Cai W. Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor Cells. Cell Mol Gastroenterol Hepatol 2021;12:81-98. [PMID: 33497867 DOI: 10.1016/j.jcmgh.2021.01.013] [Reference Citation Analysis]
92 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
93 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
94 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
95 Yang M, Peng B, Zhuang Q, Li J, Liu H, Cheng K, Ming Y. Models to predict the short-term survival of acute-on-chronic liver failure patients following liver transplantation. BMC Gastroenterol 2022;22:80. [PMID: 35196992 DOI: 10.1186/s12876-022-02164-6] [Reference Citation Analysis]
96 Kulkarni AV, Kumar P, Sharma M, Ravikumar ST, Tevethia H, Vasireddy S, Gupta R, Reddy DN, Rao PN. Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure-A Pilot Study. J Clin Exp Hepatol 2021;11:573-8. [PMID: 34511818 DOI: 10.1016/j.jceh.2020.12.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Gama JFG, Cardoso LMDF, Lagrota-Candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? World J Clin Cases 2022; 10(9): 2685-2697 [DOI: 10.12998/wjcc.v10.i9.2685] [Reference Citation Analysis]
98 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
99 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
100 Wang Y, Dong F, Sun S, Wang X, Zheng X, Huang Y, Li B, Gao Y, Qian Z, Liu F, Lu X, Liu J, Ren H, Zheng Y, Yan H, Deng G, Qiao L, Zhang Y, Gu W, Xiang X, Zhou Y, Xu B, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Qi T, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Zhang W, Li H, Meng Z. Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis. Front Med (Lausanne) 2021;8:762291. [PMID: 34869468 DOI: 10.3389/fmed.2021.762291] [Reference Citation Analysis]
101 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
102 Tan NH, Chen B, Peng J, Du S. Treg/Th17 Cell Balance in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure at Different Disease Stages. Biomed Res Int 2021;2021:9140602. [PMID: 34869773 DOI: 10.1155/2021/9140602] [Reference Citation Analysis]
103 Xu X, Hou Z, Xu Y, Gu H, Liang G, Huang Y. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol 2021;45:101482. [PMID: 32600902 DOI: 10.1016/j.clinre.2020.06.008] [Reference Citation Analysis]
104 Gama JFG, Cardoso LMDF, Lagrota-candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? WJCC 2022;10:2687-99. [DOI: 10.12998/wjcc.v10.i9.2687] [Reference Citation Analysis]
105 Yoon U, Topper J, Goldhammer J. Preoperative Evaluation and Anesthetic Management of Patients With Liver Cirrhosis Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2020:S1053-0770(20)30816-8. [PMID: 32891522 DOI: 10.1053/j.jvca.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Duseja A, De A, Taneja S, Choudhury AK, Devarbhavi H, Hu J, Hamid SS, Butt AS, Jafri SMW, Ghazinian H, Chawla YK, Dhiman RK, Duan Z, Chen Y, Tan SS, Lee GH, Lim SG, Kim DJ, Sahu M, Sollano JD, Carpio G, Mohan Prasad VG, Abbas Z, Lesmana LA, Lesmana CR, Eapen CE, Goel A, Sood A, Midha V, Goyal O, Dokmeci AK, Ning Q, Chen T, Ma K, Payawal DA, Lau GKK, Al Mahtab M, Rahman S, Alam MS, Shukla A, Shrestha A, Shah S, Kalal CR, Kumar G, Jain P, Paulson I, Sarin SK; APASL ACLF Working Party, APASL ACLF Research Consortium (AARC). Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. Liver Int 2021;41:150-7. [PMID: 32970356 DOI: 10.1111/liv.14671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
107 Jha P, Jha AK, Dayal VM, Jha SK, Kumar A. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure. Indian J Gastroenterol 2022. [PMID: 34981441 DOI: 10.1007/s12664-021-01201-8] [Reference Citation Analysis]
108 Praharaj DL, Premkumar M, Roy A, Verma N, Taneja S, Duseja A, Dhiman RK. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Chen S, Wang Y, Huang S, Wu D, Li Y, Zhong Z, Xue Y, Li H, Mu J, Tang M. Effects of Silicone Mattress Combined with Hydrocolloid Dressing on Pressure Ulcers and Phlebitis in ICU Patients with Liver Failure. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/7828650] [Reference Citation Analysis]
110 Yadav P, Trehanpati N, Maiwall R, Sehgal R, Singh R, Islam M, Jagdish RK, Vijayaraghavan R, Maheshwari D, Bhat S, Kale P, Kumar A, Baweja S, Kumar G, Ramakrishna G, Sarin SK. Soluble factors and suppressive monocytes can predict early development of sepsis in acute-on-chronic liver failure. Hepatol Commun 2022. [PMID: 35502507 DOI: 10.1002/hep4.1949] [Reference Citation Analysis]
111 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M;  APASL COVID Task Force; APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
112 Lau G, Yu ML, Wong G, Thompson A, Ghazinian H, Hou JL, Piratvisuth T, Jia JD, Mizokami M, Cheng G, Chen GF, Liu ZW, Baatarkhuu O, Cheng AL, Ng WL, Lau P, Mok T, Chang JM, Hamid S, Dokmeci AK, Gani RA, Payawal DA, Chow P, Park JW, Strasser SI, Mohamed R, Win KM, Tawesak T, Sarin SK, Omata M. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hepatol Int 2021;15:1031-48. [PMID: 34427860 DOI: 10.1007/s12072-021-10239-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
113 Cao Y, Fan Y, Wang Y, Liu X, Xie W. Acute-on-chronic Liver Failure in a Patient with Candida Endophthalmitis: A Case Report. J Clin Transl Hepatol 2021;9:447-51. [PMID: 34221931 DOI: 10.14218/JCTH.2020.00092] [Reference Citation Analysis]
114 Zaccherini G, Tufoni M, Bernardi M, Caraceni P. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. J Clin Med 2021;10:4590. [PMID: 34640608 DOI: 10.3390/jcm10194590] [Reference Citation Analysis]
115 Fang P, Dou B, Liang J, Hou W, Ma C, Zhang Q. Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats. Evid Based Complement Alternat Med 2021;2021:2898995. [PMID: 34904016 DOI: 10.1155/2021/2898995] [Reference Citation Analysis]
116 Cao Z, Liu Y, Cai M, Xu Y, Xiang X, Zhao G, Cai W, Wang H, Wang W, Xie Q. The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis. Am J Gastroenterol 2020;115:2026-35. [PMID: 32858565 DOI: 10.14309/ajg.0000000000000771] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
117 Qiao L, Tan W, Wang X, Zheng X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shang J, Liu J, Yan H, Gu W, Zhang Y, Xiang X, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Chen J, Deng G, Zhang W, Li H. Different Effects of Total Bilirubin on 90-Day Mortality in Hospitalized Patients With Cirrhosis and Advanced Fibrosis: A Quantitative Analysis. Front Med (Lausanne) 2021;8:704452. [PMID: 34249983 DOI: 10.3389/fmed.2021.704452] [Reference Citation Analysis]
118 Ko SF, Chen YL, Sung PH, Chiang JY, Chu YC, Huang CC, Huang CR, Yip HK. Hepatic 31 P-magnetic resonance spectroscopy identified the impact of melatonin-pretreated mitochondria in acute liver ischaemia-reperfusion injury. J Cell Mol Med 2020;24:10088-99. [PMID: 32691975 DOI: 10.1111/jcmm.15617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
119 Çoruh B, Pasnick S, Acho M, Bass GD, Baston CM, Elizabeth Card M, Gallo de Moraes A, Griffeth VEM, Kanj A, Leveno MJ, Lovin D, Maximous SI, Pearson SD, Stephens RS, Wolfe KS, Zakhary B, McSparron JI, Hayes MM. ATS Core Curriculum 2020. Adult Critical Care Medicine. ATS Sch 2020;1:436-55. [PMID: 33870312 DOI: 10.34197/ats-scholar.2020-0015RE] [Reference Citation Analysis]
120 Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol 2021;74:1295-302. [PMID: 33347952 DOI: 10.1016/j.jhep.2020.12.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
121 Xie Z, Ding L, Li Y. Computed Tomography Image Features under Convolutional Neural Network Algorithm in Analysis of Inflammatory Factor Level and Prognosis of Patients with Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure. J Healthc Eng 2021;2021:2110612. [PMID: 34790343 DOI: 10.1155/2021/2110612] [Reference Citation Analysis]
122 He Y, Yao H, Ageno W, Méndez-Sánchez N, Guo X, Qi X. Review article: thromboelastography in liver diseases. Aliment Pharmacol Ther 2022. [PMID: 35698893 DOI: 10.1111/apt.17080] [Reference Citation Analysis]
123 Yang Z, Zhang Z, Cheng Q, Chen G, Li W, Ma K, Guo W, Luo X, Chen T, Ning Q. Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients. Hepatol Int 2020;14:491-502. [PMID: 32472309 DOI: 10.1007/s12072-020-10053-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Zhu B, You S, Rong Y, Yu Q, Lv S, Song F, Liu H, Wang H, Zhao J, Li D, Liu W, Xin S. A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure. Braz J Med Biol Res 2020;53:e9728. [PMID: 33053116 DOI: 10.1590/1414-431X20209728] [Reference Citation Analysis]
125 Nababan SHH, Mansjoer A, Fauzi A, Gani RA. Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia. BMC Gastroenterol 2021;21:392. [PMID: 34670501 DOI: 10.1186/s12876-021-01972-6] [Reference Citation Analysis]
126 Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther 2020;37:1452-63. [PMID: 32076942 DOI: 10.1007/s12325-020-01250-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
127 Wang ML, Yin XJ, Li XL, Wang FD, Zhou J, Tao YC, Wang YH, Wu DB, Chen EQ. Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:724224. [PMID: 34422872 DOI: 10.3389/fmed.2021.724224] [Reference Citation Analysis]
128 Xiong Y, Xia Z, Yang L, Huang J. Low T3 syndrome is associated with poor prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol 2022;:1-7. [PMID: 35723536 DOI: 10.1080/17474124.2022.2090336] [Reference Citation Analysis]
129 Huang Y, Yan D, Zhang H, Lou B, Yan R, Yao Y, Dong M, Yang D, Lv F, Chen Y. Lower testosterone levels predict increasing severity and worse outcomes of hepatitis B virus-related acute-on-chronic liver failure in males. BMC Gastroenterol 2021;21:457. [PMID: 34872528 DOI: 10.1186/s12876-021-01993-1] [Reference Citation Analysis]
130 Rui F, Yang H, Guo Z, Ge Z, Hu X, Zhang L, Xue Q, Chen H, Xu Y, Tan M, Qin C, He Z, Li J. Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients. J Viral Hepat 2021;28:1719-28. [PMID: 34496100 DOI: 10.1111/jvh.13611] [Reference Citation Analysis]
131 Li L, Chen L, Lin F, Mu J, Wang D, Zhang W, Mi L, Qin Y, Zhou Y. Study of the Expression of Inflammatory Factors IL-4, IL-6, IL-10, and IL-17 in Liver Failure Complicated by Coagulation Dysfunction and Sepsis. J Inflamm Res 2021;14:1447-53. [PMID: 33883921 DOI: 10.2147/JIR.S302975] [Reference Citation Analysis]
132 Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2022;71:148-55. [PMID: 33436495 DOI: 10.1136/gutjnl-2020-322161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
133 Kaur S, Hussain S, Kolhe K, Kumar G, Tripathi DM, Tomar A, Kale P, Narayanan A, Bihari C, Bajpai M, Maiwall R, Gupta E, Sarin SK. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep 2021;3:100303. [PMID: 33997748 DOI: 10.1016/j.jhepr.2021.100303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Pfingstgraf IO, Taulescu M, Pop RM, Orăsan R, Vlase L, Uifalean A, Todea D, Alexescu T, Toma C, Pârvu AE. Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure. Antioxidants (Basel) 2021;10:504. [PMID: 33804908 DOI: 10.3390/antiox10040504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Kumar SE, Goel A, Zachariah U, Nair SC, David VG, Varughese S, Gandhi PB, Barpha A, Sharma A, Vijayalekshmi B, Balasubramanian KA, Elias E, Eapen CE. Low Volume Plasma Exchange and Low Dose Steroid Improve Survival in Patients With Alcohol-Related Acute on Chronic Liver Failure and Severe Alcoholic Hepatitis – Preliminary Experience. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.07.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Mataya LA, Srinivasan V, Rand EB, Alcamo AM. Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children. Transl Pediatr 2021;10:2749-62. [PMID: 34765498 DOI: 10.21037/tp-20-375] [Reference Citation Analysis]
137 He X, Chen L, Chen H, Feng Y, Zhu B, Yang C. Diagnostic Accuracy of Procalcitonin for Bacterial Infection in Liver Failure: A Meta-Analysis. Bioinorg Chem Appl 2021;2021:5801139. [PMID: 34646316 DOI: 10.1155/2021/5801139] [Cited by in Crossref: 10] [Article Influence: 10.0] [Reference Citation Analysis]
138 Lin X, Huang X, Wang L, Feng S, Chen X, Cai W, Huang Z. Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF. Med Sci Monit 2020;26:e926574. [PMID: 32978936 DOI: 10.12659/MSM.926574] [Reference Citation Analysis]
139 Tong J, Wang H, Xu X, Wan Z, Fang H, Chen J, Mu X, Liu Z, Chen J, Su H, Liu X, Li C, Huang X, Hu J. Granulocyte Colony-Stimulating Factor Accelerates the Recovery of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure by Promoting M2-Like Transition of Monocytes. Front Immunol 2022;13:885829. [DOI: 10.3389/fimmu.2022.885829] [Reference Citation Analysis]
140 Xu X, Wang H, Zhao W, Wang Y, Wang J, Qin B. Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study. BMJ Open 2021;11:e043083. [PMID: 34162632 DOI: 10.1136/bmjopen-2020-043083] [Reference Citation Analysis]
141 Abdallah MA, Waleed M, Bell MG, Nelson M, Wong R, Sundaram V, Singal AK. Systematic review with meta-analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure. Aliment Pharmacol Ther 2020;52:222-32. [DOI: 10.1111/apt.15793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
142 Guo Y, Zhu Z, Wu W, Huang D, Zheng H, Xu Z, Li X, Wang N, Qin J, Liu Y, Liu L, Nashan B. Liver Transplantation in a Patient With Acute-on-Chronic Liver Failure Due to Traditional Chinese Medicine Intoxication Using Donation After Circulatory Death From a Renal Transplant Recipient: A Case Report. Transplant Proc 2020;52:2813-6. [PMID: 32900476 DOI: 10.1016/j.transproceed.2020.08.003] [Reference Citation Analysis]
143 Raju B, Andani A, Kolhapure S, Agrawal A. Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India. Hum Vaccin Immunother 2021;17:1520-9. [PMID: 33236963 DOI: 10.1080/21645515.2020.1832408] [Reference Citation Analysis]
144 Zheng Y, Zhu S, Zheng X, Xu W, Li X, Li J, Gao Z, Xie C, Peng L. Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells. J Clin Transl Hepatol 2021;9:503-13. [PMID: 34447679 DOI: 10.14218/JCTH.2021.00014] [Reference Citation Analysis]
145 Jindal A, Sarin SK, Kumar M, Kumar G. Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient ≤ 10 mm Hg. Dig Dis Sci 2022. [PMID: 35113276 DOI: 10.1007/s10620-021-07334-2] [Reference Citation Analysis]
146 Verma N, Mehtani R, Duseja A. Universal definition and prognostication in acute-on-chronic liver failure - an unmet need! J Hepatol 2021:S0168-8278(21)01900-0. [PMID: 34246704 DOI: 10.1016/j.jhep.2021.06.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Han HS, Park CM, Lee DS, Sinn DH, Gil E. Evaluating mortality and recovery of extreme hyperbilirubinemia in critically ill patients by phasing the peak bilirubin level: A retrospective cohort study. PLoS One 2021;16:e0255230. [PMID: 34351969 DOI: 10.1371/journal.pone.0255230] [Reference Citation Analysis]
148 Gambino C, Piano S, Angeli P. Acute-on-Chronic Liver Failure in Cirrhosis. J Clin Med 2021;10:4406. [PMID: 34640424 DOI: 10.3390/jcm10194406] [Reference Citation Analysis]
149 Ferstl P, Trebicka J. Acute Decompensation and Acute-on-Chronic Liver Failure. Clin Liver Dis 2021;25:419-30. [PMID: 33838858 DOI: 10.1016/j.cld.2021.01.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 He Y, Guo X, Lan T, Xia J, Wang J, Li B, Peng C, Chen Y, Hu X, Meng Z. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling. Stem Cell Res Ther 2021;12:396. [PMID: 34256837 DOI: 10.1186/s13287-021-02468-6] [Reference Citation Analysis]
151 Sharma S, Agarwal S, Gopi S, Anand A, Mohta S, Gunjan D, Yadav R, Saraya A. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. J Clin Exp Hepatol 2021;11:171-80. [PMID: 33746441 DOI: 10.1016/j.jceh.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Li L, Chen L, Wang H, Li P, Wang D, Zhang W, Mi L, Lin F, Qin Y, Zhou Y. Clinical correlation between coagulation disorders and sepsis in patients with liver failure. Clin Hemorheol Microcirc 2021. [PMID: 34719481 DOI: 10.3233/CH-211113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
153 Bai J, Li L, Liu H, Liu S, Bai L, Song W, Chen Y, Zheng S, Duan Z. UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults. J Clin Transl Hepatol 2021;9:180-6. [PMID: 34007799 DOI: 10.14218/JCTH.2020.00108] [Reference Citation Analysis]
154 Liu Y, He S, Yin S, Zhong Q, Zhong J, Zhang X, Fan R, Hou J. Prevalence of Dual-Positivity for Both Hepatitis B e Antigen and Hepatitis B e Antibody Among Hospitalized Patients with Chronic Hepatitis B Virus Infection. Int J Gen Med 2021;14:5759-70. [PMID: 34557028 DOI: 10.2147/IJGM.S328714] [Reference Citation Analysis]
155 Uludag K, Arikan T. Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment. Ann Saudi Med 2021;41:361-8. [PMID: 34873933 DOI: 10.5144/0256-4947.2021.361] [Reference Citation Analysis]
156 Li J, Wu T, Zhang X, Du Y, Wei B, Wang J. Clinical Application of Liver Diseases Diagnosis using Ultrahigh-sensitive Liquid Chromatography-Mass Spectrometry for Sialic Acids Detection. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.462837] [Reference Citation Analysis]
157 Maiwall R, Sarin SK. Plasma Exchange in Acute and Acute on Chronic Liver Failure. Semin Liver Dis 2021. [PMID: 34261138 DOI: 10.1055/s-0041-1730971] [Reference Citation Analysis]
158 Zhang Y, Xu W, Zhu X, Li X, Li J, Shu X, Lai J, Xie J, Xie C, Peng L. The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study. J Viral Hepat. 2021;28:592-600. [PMID: 33423348 DOI: 10.1111/jvh.13468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Xu W, Li Y, Wang L, Gao H, Chen J, Yuan J, Ouyang Y, Gao Y, Li J, Li X, Peng L. Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial. BMJ Open 2021;11:e047690. [PMID: 34907041 DOI: 10.1136/bmjopen-2020-047690] [Reference Citation Analysis]
160 Xiao KY, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS, Mahmud N. Models for acute on chronic liver failure development and mortality in a veterans affairs cohort. Hepatol Int 2020;14:587-96. [PMID: 32519219 DOI: 10.1007/s12072-020-10060-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
161 Tan J, He Y, Li Z, Zhang Q, Yang Y, Xu Q, Xu X. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions. Front Public Health 2022;10:919549. [DOI: 10.3389/fpubh.2022.919549] [Reference Citation Analysis]
162 Hu C, Huang K, Zhao L, Zhang F, Wu Z, Li L. Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure. Sci Rep. 2020;10:16970. [PMID: 33046732 DOI: 10.1038/s41598-020-73603-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Lu CY, Chen CL, Ho CM, Hsiao CY, Wu YM, Ho MC, Lee PH, Hu RH. Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure. J Pers Med 2020;10:E230. [PMID: 33203142 DOI: 10.3390/jpm10040230] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Liu S, Meng Q, Xu Y, Zhou J. Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. Gastroenterol Rep (Oxf) 2021;9:505-20. [PMID: 34925848 DOI: 10.1093/gastro/goab040] [Reference Citation Analysis]
165 Lee HW, Yip TC, Tse YK, Wong GL, Kim BK, Kim SU, Park JY, Kim DY, Chan HL, Ahn SH, Wong VW. Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2020;. [PMID: 32889148 DOI: 10.1016/j.cgh.2020.08.064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
166 Singh H, Kelgeri C, Passingham C, Johansen L, van Mourik I, Ong E, Perera MTPR, Mirza D, Sharif K, Hartley J, Gupte GL. Acute-on-chronic liver failure: A 20-year retrospective review of a tertiary paediatric liver centre. Acta Paediatr 2022;111:1435-40. [PMID: 35390187 DOI: 10.1111/apa.16352] [Reference Citation Analysis]
167 Hu H, Hu X, Tian C, Zhu Y, Liu Y, Cheng Q, Yang F, Liu J, Li Y, Lin S. Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int 2021. [PMID: 34373965 DOI: 10.1007/s12072-021-10243-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 Yang Q, Zhou Z, Yang X, Chen Y, Liu A, Zhang B, Shao L, Zheng J, Zhang W. Latent Cytomegalovirus Reactivation in Patients With Liver Failure: A 10-Year Retrospective Case-Control Study, 2011-2020. Front Cell Infect Microbiol 2021;11:642500. [PMID: 34041042 DOI: 10.3389/fcimb.2021.642500] [Reference Citation Analysis]
169 Doycheva I, Thuluvath PJ. Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis. Transl Gastroenterol Hepatol 2020;5:38. [PMID: 32632389 DOI: 10.21037/tgh.2019.10.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
170 Zhang XQ, Zeng J, Jin JY, Wang JF, Chi YY, Zheng RQ. Shear-Wave Dispersion Slope of the Liver: Effect of Study Protocol and Ascites on the Measurement Applicability. Ultrasound Med Biol 2022;48:59-67. [PMID: 34702641 DOI: 10.1016/j.ultrasmedbio.2021.09.012] [Reference Citation Analysis]
171 Premkumar M, Sarin SK. Current Concepts in Coagulation Profile in Cirrhosis and Acute-on-Chronic Liver Failure. Clin Liver Dis (Hoboken) 2020;16:158-67. [PMID: 33163169 DOI: 10.1002/cld.976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
172 Li C, Su HB, Liu XY, Hu JH. Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2020; 8(6): 1042-1055 [PMID: 32258075 DOI: 10.12998/wjcc.v8.i6.1042] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
173 Maruyama H, Shiina S. Connection between HPS and ACLF: a solution of chaos? Hepatol Int 2021;15:1049-52. [PMID: 34606063 DOI: 10.1007/s12072-021-10255-x] [Reference Citation Analysis]
174 Huang W, Ma Y, Du L, Kang S, Liu CH, Bai L, Lei X, Tang H. Effectiveness of granulocyte colony-stimulating factor for patients with acute-on-chronic liver failure: a meta-analysis. Ann Saudi Med 2021;41:383-91. [PMID: 34873932 DOI: 10.5144/0256-4947.2021.383] [Reference Citation Analysis]
175 Shen G, Sun S, Huang J, Deng H, Xu Y, Wang Z, Tang X, Gong X. Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int. 2020;14:47-56. [PMID: 31872330 DOI: 10.1007/s12072-019-10008-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
176 Tian C, Zhu Y, Liu Y, Hu H, Cheng Q, Yang F, Pei L, Zhou Y, Li Y, Lin S. High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis. Front Cell Infect Microbiol 2022;12:721138. [DOI: 10.3389/fcimb.2022.721138] [Reference Citation Analysis]
177 Rastogi A, Patil N, Maiwall R, Bihari C, Soshee A, Sarin SK. Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis. Virchows Arch 2021. [PMID: 33797570 DOI: 10.1007/s00428-021-03089-3] [Reference Citation Analysis]
178 Sharma P. Value of Liver Function Tests in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.004] [Reference Citation Analysis]
179 Jophlin L, Singal AK. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.009] [Reference Citation Analysis]
180 Zhou J, Chen S, Zhang L, Zhai Y. Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report. Daru 2021. [PMID: 34817844 DOI: 10.1007/s40199-021-00420-w] [Reference Citation Analysis]
181 Islek A, Tumgor G. Acute-on-chronic liver failure in children. World J Hepatol 2021; 13(10): 1289-1298 [PMID: 34786166 DOI: 10.4254/wjh.v13.i10.1289] [Reference Citation Analysis]
182 Zhang M, Xu X, Liu W, Zhang Z, Cheng Q, Yang Z, Liu T, Liu Y, Ning Q, Chen T, Qi J. Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure. Adv Ther 2021;38:4675-94. [PMID: 34308513 DOI: 10.1007/s12325-021-01844-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
184 Jia L, Xue R, Zhu Y, Zhao J, Li J, He WP, Wang XM, Duan ZH, Ren MX, Liu HX, Xing HC, Meng QH. The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial. BMC Med 2020;18:383. [PMID: 33287816 DOI: 10.1186/s12916-020-01814-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 Li J, Gong QM, Xie PL, Lin JY, Chen J, Wei D, Yu DM, Han Y, Zhang XX. Prognostic value of anti-HBc quantification in hepatitis B virus related acute-on-chronic liver failure. J Gastroenterol Hepatol 2021;36:1291-9. [PMID: 33091955 DOI: 10.1111/jgh.15310] [Reference Citation Analysis]
186 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, Nirei K, Moriyama M. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci 2020;21:E6384. [PMID: 32887515 DOI: 10.3390/ijms21176384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]